Sun Communities, Inc. Commences Public Offering of 7,000,000 Shares of Common Stock
March 04, 2021 07:01 ET | Sun Communities, Inc.
Southfield, MI, March 04, 2021 (GLOBE NEWSWIRE) -- Sun Communities, Inc. (NYSE:SUI) (the “Company”), a real estate investment trust (“REIT”) that owns and operates or has an interest in...
EN-RAYSecur-logo-Black.jpg
RaySecur Wins Prism Award for Security Imaging Innovation
March 04, 2021 07:01 ET | RaySecur Inc.
RaySecur™ receives prestigious Prism Award for its MailSecur™ scanner, selected as the top new optics and photonics innovation in security technology for 2021. CAMBRIDGE, Mass., March 04, 2021 ...
Fulcrum-Logo_Primary_Full-Color_RGB_Large copy.jpg
Fulcrum Therapeutics Reports Recent Business Highlights and Fourth Quarter and Full Year 2020 Financial Results
March 04, 2021 07:01 ET | Fulcrum Therapeutics
– Company on track to present data from Phase 2b ReDUX4 trial with losmapimod in facioscapulohumeral muscular dystrophy (FSHD) in late-2Q 2021 – – On track to report results from Phase 1 trial in...
HUTCHMED-spaced-1000x1000-WhiteBgd.jpg
Hutchison China MediTech Limited Reports 2020 Full Year Results and Provides Business Updates and Evolves Corporate Identity
March 04, 2021 07:00 ET | Hutchison China MediTech Limited
HONG KONG and SHANGHAI and FLORHAM PARK, N.J., March 04, 2021 (GLOBE NEWSWIRE) -- Hutchison China MediTech Limited (“HUTCHMED”) (Nasdaq/AIM: HCM), an innovation-driven, commercial-stage...
BBDLOGO.jpg
Bombardier Provides 2025 Financial Targets and Highlights Progress on Key Earnings Growth and Cash Generation Drivers at Virtual Investor Day
March 04, 2021 07:00 ET | Bombardier Inc.
MONTREAL, March 04, 2021 (GLOBE NEWSWIRE) -- Bombardier (TSX: BBD.B) today will host its virtual Investor Day, during which the company’s leadership team will provide its 2025 financial targets and...
Hookipa Pharma Logo Square.png
Pre-clinical data on HOOKIPA’s alternating 2-vector cancer therapeutics published in Cell Reports Medicine
March 04, 2021 07:00 ET | Hookipa Pharma Inc
Alternating, intravenous administration of two replicating arenaviral vectors induce tumor-specific responses exceeding 50% of the circulating CD8 T cells2-vector approach resulted in tumor cures and...
NeptuneDash_Icon_DAC-1500x500-white-bg.png
Neptune Digital Assets Announces Bitcoin Mining Operations and Partnership With Link Global
March 04, 2021 07:00 ET | Neptune Digital Assets Corp.
VANCOUVER, British Columbia, March 04, 2021 (GLOBE NEWSWIRE) -- Neptune Digital Assets Corp. (TSX-V:NDA) (OTC:NPPTF) (FSE:1NW) (“Neptune” or the "Company") is excited to announce that it will begin...
LRMR Logo.png
Larimar Therapeutics Reports Fourth Quarter and Full Year 2020 Operating and Financial Results
March 04, 2021 07:00 ET | Larimar Therapeutics
Reported preliminary Phase 1 findings from a Single Ascending Dose (SAD) trial that suggest single subcutaneous injections of CTI-1601 were well tolerated at doses up to 100 mg in Friedreich's ataxia...
CSL_4c Logo.png
Capital Senior Living to Present and Host Investor Meetings at Barclay's Global Healthcare Conference
March 04, 2021 07:00 ET | Capital Senior Living Corporation
DALLAS, March 04, 2021 (GLOBE NEWSWIRE) -- Capital Senior Living Corporation (the “Company” or “Capital Senior Living”) (NYSE: CSU), a leading owner/operator of senior living communities and...
LOGO.png
Autolus Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Operational Progress
March 04, 2021 07:00 ET | Autolus Therapeutics plc
LONDON, March 04, 2021 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (Nasdaq: AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, today announced...